Differentiating nonhigh-grade duct carcinoma in situ from benign breast lesions
β Scribed by Marian Priyanthi Kumarasinghe; Wee Teng Poh
- Book ID
- 102140261
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 295 KB
- Volume
- 30
- Category
- Article
- ISSN
- 8755-1039
- DOI
- 10.1002/dc.10423
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
This study was undertaken to determine the discriminating cytological features between nonhighβgrade duct carcinoma in situ (NHGDCIS) and benign breast lesions and to determine any histological characteristics which would influence the cytological categorization. Smears of 12 each of histologically confirmed NHGDCIS and benign breast lesions were reviewed with regard to cellularity, cell discohesion, nuclear atypia, crowding of cells, tubule formation, necrosis, and presence of bare atypical nuclei and regular bare bipolar nuclei, and statistically analyzed. Architectural pattern, presence of necrosis, and the size of the lesion assessed at histological examination were compared with the initial cytological categorization. NHGDCIS lesions showed more cell discohesion (P = 0.04), bare atypical nuclei (P = 0.05), necrosis (P = 0.03), and sparse bare bipolar nuclei (P = 0.02) than benign lesions. These differences were statistically significant. Cellularity (P = 0.8), nuclear atypia (P = 0.06), crowding of cells (P = 0.1), and tubule formation did not show a significant difference. Six (out of six lesions) with a solid architectural pattern and six (of seven) with necrosis could be cytologically categorized as suspicious or malignant. Size of the lesion did not influence this. We conclude that cell discohesion, bare atypical and bare bipolar nuclei, and necrosis are discriminating features between NHGDCIS and benign breast lesions and NHGDCIS lesions with a solid architectural pattern and necrosis are more likely to be satisfactorily categorized cytologically. Diagn. Cytopathol. 2004;30:98β102. Β© 2004 WileyβLiss, Inc.
π SIMILAR VOLUMES
In the last 6 years a number of non-randomized, predominantly single institutional trials of breast conservation therapy (BCT) with DCIS, have demonstrated that it constitutes a very heterogeneous group of diseases with markedly different risks of local recurrence and invasive transformation. There